01290aam 2200373I 450 991071005850332120151118015323.0GOVPUB-C13-a0ec23ae6218860ba336d47206900350(CKB)5470000002475691(OCoLC)929881438(EXLCZ)99547000000247569120151118d1974 ua 0engrdacontentrdamediardacarrierElectrodeposition of chromium with periodic reverse and pulsed current /John P. YoungGaithersburg, MD :U.S. Dept. of Commerce, National Institute of Standards and Technology,1974.1 online resourceNBSIR ;74-5981974.Contributed record: Metadata reviewed, not verified. Some fields updated by batch processes.Title from PDF title page.Includes bibliographical references.Young John P13102Young John P13102United States.National Bureau of Standards.NBSNBSGPOBOOK9910710058503321Electrodeposition of chromium with periodic reverse and pulsed current3435412UNINA04308nam 2201465z- 450 991056647370332120220506(CKB)5680000000037643(oapen)https://directory.doabooks.org/handle/20.500.12854/81202(oapen)doab81202(EXLCZ)99568000000003764320202205d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierMolecular Pathways in CancersBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (284 p.)3-0365-3682-5 3-0365-3681-7 This book includes some recent works providing the readers with novel relevant findings about the main signaling pathways that govern the molecular pathogenesis of some of the highest prevalent human tumors, which are the basis for developing alternative therapeutic strategies to improve patient outcomes.Medicine and NursingbicsscOncologybicsscacetylationactin cytoskeletal reorganizationadaptive immunityadvanced ovarian canceranti-receptor therapyBET inhibitorsbiomarkersbladder cancer initiationbreast cancerCALRcancercancer immunologycancer therapeuticscarcinogenicityCD99 agonistcomplement systemDUSP1EGFR dimerizationendocytosisepigeneticepigenomeepithelial cellsFAK dephosphorylationgenomeglioblastomagp120hepatocellular carcinomahuman immunodeficiency virus type 1immune checkpoint inhibitorsimmune evasionimmunotherapyinnate immunityJAK2luminal breast cancerMAPKmatrix protein p17metastasismetastatic melanomamethylationmigration and invasionmitochondriamolecular targeted agentsMPLMS-determined phosphopeptidesmTORmyeloproliferative neoplasmsn/aNefNIMA-related kinase 1 (NEK1)non-coding RNAOMDoncogenic signaling pathwayovarian canceroxidative stressOXPHOSpancreatic ductal adenocarcinomapartial EMTpatient survivalpBRD4PI3KPP2APRELPprognosisprostate cancerPTPN12Rac1reactive oxygen speciesresistancereverse transcriptaseRhoASETsignaling pathwayssmall-cell lung cancerSnailsplicing pathwayTAK-228Tatthioridazine (THD)tight junctiontousled-like kinase (TLK)TPORtrastuzumabtripeptidetriple negative breast cancertriple-negative breast cancertumor immune microenvironmenttumor microenvironmenttumor suppression geneWarburg effectyes-associated protein 1 (YAP1)Medicine and NursingOncologyCristóbal Ionedt1309570Rodríguez MartaedtCristóbal IonothRodríguez MartaothBOOK9910566473703321Molecular Pathways in Cancers3029401UNINA